ENTECH SACA (ALESE.PA) Fundamental Analysis & Valuation

EPA:ALESE • FR0014004362

Current stock price

9.66 EUR
-0.4 (-3.98%)
Last:

This ALESE.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. ALESE.PA Profitability Analysis

1.1 Basic Checks

  • ALESE had negative earnings in the past year.
  • In the past year ALESE had a positive cash flow from operations.
  • ALESE had negative earnings in 4 of the past 5 years.
  • In the past 5 years ALESE always reported negative operating cash flow.
ALESE.PA Yearly Net Income VS EBIT VS OCF VS FCFALESE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -2M -4M -6M -8M -10M

1.2 Ratios

  • ALESE has a worse Return On Assets (-3.88%) than 91.11% of its industry peers.
  • Looking at the Return On Equity, with a value of -11.31%, ALESE is doing worse than 91.11% of the companies in the same industry.
Industry RankSector Rank
ROA -3.88%
ROE -11.31%
ROIC N/A
ROA(3y)-2.34%
ROA(5y)-0.87%
ROE(3y)-4.85%
ROE(5y)-2.97%
ROIC(3y)N/A
ROIC(5y)N/A
ALESE.PA Yearly ROA, ROE, ROICALESE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

  • Looking at the Gross Margin, with a value of 42.82%, ALESE is in line with its industry, outperforming 60.00% of the companies in the same industry.
  • ALESE's Gross Margin has declined in the last couple of years.
  • ALESE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 42.82%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.07%
GM growth 5YN/A
ALESE.PA Yearly Profit, Operating, Gross MarginsALESE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. ALESE.PA Health Analysis

2.1 Basic Checks

  • ALESE does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, ALESE has about the same amount of shares outstanding.
  • ALESE has a worse debt/assets ratio than last year.
ALESE.PA Yearly Shares OutstandingALESE.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 5M 10M
ALESE.PA Yearly Total Debt VS Total AssetsALESE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • ALESE has an Altman-Z score of 2.57. This is not the best score and indicates that ALESE is in the grey zone with still only limited risk for bankruptcy at the moment.
  • The Altman-Z score of ALESE (2.57) is better than 75.56% of its industry peers.
  • ALESE has a debt to FCF ratio of 1.80. This is a very positive value and a sign of high solvency as it would only need 1.80 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 1.80, ALESE is in the better half of the industry, outperforming 77.78% of the companies in the same industry.
  • A Debt/Equity ratio of 0.27 indicates that ALESE is not too dependend on debt financing.
  • ALESE has a Debt to Equity ratio of 0.27. This is in the better half of the industry: ALESE outperforms 68.89% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF 1.8
Altman-Z 2.57
ROIC/WACCN/A
WACC7.71%
ALESE.PA Yearly LT Debt VS Equity VS FCFALESE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

  • ALESE has a Current Ratio of 1.57. This is a normal value and indicates that ALESE is financially healthy and should not expect problems in meeting its short term obligations.
  • ALESE has a Current ratio of 1.57. This is amongst the best in the industry. ALESE outperforms 82.22% of its industry peers.
  • A Quick Ratio of 1.51 indicates that ALESE should not have too much problems paying its short term obligations.
  • ALESE has a Quick ratio of 1.51. This is amongst the best in the industry. ALESE outperforms 86.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.57
Quick Ratio 1.51
ALESE.PA Yearly Current Assets VS Current LiabilitesALESE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. ALESE.PA Growth Analysis

3.1 Past

  • The earnings per share for ALESE have decreased strongly by -294.30% in the last year.
  • ALESE shows a strong growth in Revenue. In the last year, the Revenue has grown by 32.45%.
  • The Revenue has been growing by 68.95% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-294.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%97.21%
Revenue 1Y (TTM)32.45%
Revenue growth 3Y68.95%
Revenue growth 5YN/A
Sales Q2Q%56.95%

3.2 Future

  • The Earnings Per Share is expected to grow by 116.80% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, ALESE will show a very strong growth in Revenue. The Revenue will grow by 38.42% on average per year.
EPS Next Y138.1%
EPS Next 2Y125.73%
EPS Next 3Y116.8%
EPS Next 5YN/A
Revenue Next Year34.66%
Revenue Next 2Y49.35%
Revenue Next 3Y50.82%
Revenue Next 5Y38.42%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ALESE.PA Yearly Revenue VS EstimatesALESE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M 400M
ALESE.PA Yearly EPS VS EstimatesALESE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.2 0.4 0.6 0.8

More info and screens

Find the best growth stocksShow best growing peers

3

4. ALESE.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • ALESE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • With a Price/Forward Earnings ratio of 28.86, ALESE can be considered very expensive at the moment.
  • Based on the Price/Forward Earnings ratio, ALESE is valued a bit more expensive than the industry average as 73.33% of the companies are valued more cheaply.
  • ALESE's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 22.79.
Industry RankSector Rank
PE N/A
Fwd PE 28.86
ALESE.PA Price Earnings VS Forward Price EarningsALESE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, ALESE is valued a bit cheaper than the industry average as 62.22% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 10.78
EV/EBITDA N/A
ALESE.PA Per share dataALESE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as ALESE's earnings are expected to grow with 116.80% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y125.73%
EPS Next 3Y116.8%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALESE.PA Dividend Analysis

5.1 Amount

  • ALESE does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALESE.PA Fundamentals: All Metrics, Ratios and Statistics

ENTECH SACA

EPA:ALESE (3/25/2026, 7:00:00 PM)

9.66

-0.4 (-3.98%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners11.63%
Inst Owner ChangeN/A
Ins Owners63.65%
Ins Owner ChangeN/A
Market Cap142.00M
Revenue(TTM)45.47M
Net Income(TTM)-2.92M
Analysts86
Price Target12.14 (25.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)4.39%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-11.11%
EPS NY rev (3m)33.33%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-2.63%
Revenue NY rev (3m)-2.63%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 28.86
P/S 3.12
P/FCF 10.78
P/OCF 10.01
P/B 5.5
P/tB 7.22
EV/EBITDA N/A
EPS(TTM)-0.2
EYN/A
EPS(NY)0.33
Fwd EY3.47%
FCF(TTM)0.9
FCFY9.28%
OCF(TTM)0.96
OCFY9.99%
SpS3.09
BVpS1.76
TBVpS1.34
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -3.88%
ROE -11.31%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 42.82%
FCFM 28.98%
ROA(3y)-2.34%
ROA(5y)-0.87%
ROE(3y)-4.85%
ROE(5y)-2.97%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.07%
GM growth 5YN/A
F-Score3
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF 1.8
Debt/EBITDA N/A
Cap/Depr -3048.48%
Cap/Sales 2.21%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.57
Quick Ratio 1.51
Altman-Z 2.57
F-Score3
WACC7.71%
ROIC/WACCN/A
Cap/Depr(3y)285.26%
Cap/Depr(5y)212.15%
Cap/Sales(3y)7.1%
Cap/Sales(5y)9.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-294.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%97.21%
EPS Next Y138.1%
EPS Next 2Y125.73%
EPS Next 3Y116.8%
EPS Next 5YN/A
Revenue 1Y (TTM)32.45%
Revenue growth 3Y68.95%
Revenue growth 5YN/A
Sales Q2Q%56.95%
Revenue Next Year34.66%
Revenue Next 2Y49.35%
Revenue Next 3Y50.82%
Revenue Next 5Y38.42%
EBIT growth 1Y-189.7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year285.74%
EBIT Next 3Y158.85%
EBIT Next 5Y101.25%
FCF growth 1Y230.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y258.99%
OCF growth 3YN/A
OCF growth 5YN/A

ENTECH SACA / ALESE.PA Fundamental Analysis FAQ

What is the fundamental rating for ALESE stock?

ChartMill assigns a fundamental rating of 4 / 10 to ALESE.PA.


What is the valuation status for ALESE stock?

ChartMill assigns a valuation rating of 3 / 10 to ENTECH SACA (ALESE.PA). This can be considered as Overvalued.


What is the profitability of ALESE stock?

ENTECH SACA (ALESE.PA) has a profitability rating of 1 / 10.


How financially healthy is ENTECH SACA?

The financial health rating of ENTECH SACA (ALESE.PA) is 6 / 10.